Pharmacotherapy of acute lymphoblastic leukemia

A tétel rövid nézete
dc.contributor.advisorMegyeri, Attila
dc.contributor.advisordeptDepartment of Pharmacology and Pharmacotherapyhu_HU
dc.contributor.authorOryan, Tal
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentPórszász, Róbert
dc.contributor.opponentdeptKenézy Kórház Aneszteziológiai és Intenziv Therápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2017-08-02T11:12:07Z
dc.date.available2017-08-02T11:12:07Z
dc.date.created2017-02-28
dc.description.abstractThe purpose of this paper is to review the outstanding current pharmacological treatment of the newly diagnosed pediatric patient. My goal was to analyze the pharmacokinetic and pharmacodynamic characteristics of the drugs used as well as their common side effects. As the multi drug therapy can be associated with some severe cytotoxicities and relapses I was fascinated to explore how our own genes can influence the success of the treatment. In addition, a short chapter is dedicated to the relatively newly introduced, yet very promising novel therapy which target surface antigen on tumor cells.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent38hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/242825
dc.language.isoenhu_HU
dc.subjectALLhu_HU
dc.subjectpediatricshu_HU
dc.subjecttreatmenthu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titlePharmacotherapy of acute lymphoblastic leukemiahu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)